Skip to main content
. 2022 Mar 20;22:270. doi: 10.1186/s12879-022-07239-z

Table 2.

Prior distributions and initial values (obtained from CIPHA data) used for model fits

(a) Prior distributions used for initialising model fits
Name γ Prior distributions Initial values
β I,Iij eij,μi S,Sij,R,Rij
Core Model 1/7 Unif[0,10] Unif[0,100] Unif[0,1] Table 2b
Sensitivity to γ 1/3 Unif[0,10] Unif[0,100] Unif[0,1] Table 2b
Sensitivity to γ 1/11 Unif[0,10] Unif[0,100] Unif[0,1] Table 2b
Double Removed 1/7 Unif[0,10] Unif[0,100] Unif[0,1] Table 2c
(b) Initial values when assuming all infected from start of pandemic moved to removed class
S S1A S2A S1P S2P R R1A R2A R1P R2P
1266979 478347 312594 74665 384481 70887 42715 20895 6738 26715
(c) Initial values when assuming infected individuals are underestimated by 50%
S S1A S2A S1P S2P R R1A R2A R1P R2P
1196092 435632 291699 67927 357766 141774 85430 41790 13476 53430

Notation is as follows β: Transmission rate, γ: Recovery rate, eij: Effectiveness of i doses of vaccine j against infection, S: Unvaccinated susceptible individuals, Sij: Susceptible individuals who have received i doses of vaccine j, I: Unvaccinated infected individuals, Iij: Infected individuals who have received i doses of vaccine j, R: Unvaccinated removed individuals, Rij: Removed individuals who have received i doses of vaccine j, and μi: Infectiveness of an infected individual with i doses of either vaccine. For number of doses we have i{1,2} and for vaccines j{A,P} for Oxford-AstraZeneca and Pfizer-BioNTech respectively